RxDoctor Payments Data

Daniel Park, MD

Orthopaedic Surgery · Chicago, ILNPI 1073769162

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $244,146 of the $320,626 with a category attached, or 76.1%. 43 manufacturers reported payments, led by Stryker at 45.6% of the total. Reporting peaked in 2019 at $75,795 and has fallen 70.3% since, to $22,539 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$320,626in general payments, 2019–2025

Across 593 payments — averaging $540.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$146K
  • Kuros Biosciences USA, Inc$37K
  • Arthrex$31K
  • VB Spine LLC$15K
  • Nanohive Medical LLC$14K
  • Amplify Surgical, Inc.$13K
  • plus $65K from 37 others
$143,055in research payments, 2019–2025

Across 39 payments — averaging $3668.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$118K
  • Stryker$14K
  • Arthrex$8K
  • Bioventus LLC$3K
$16,335in ownership & investment interests, 2019–2025

Across 1 payment — averaging $16,335 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$16K

What the payments were for

  • Consulting fees$244,14676%
  • Travel & lodging$42,09013%
  • Food & beverage$19,6756%
  • Education$14,4625%
  • Gifts$300%
  • Entertainment$2240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$320,626 in reported general payments places this provider in the 95th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$350,440
Medicare patients
465
Services billed
1,607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$902
Gabapentin63$517
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$379
Methylprednisolone65$313
Methocarbamol52$296
Oxycodone Hcl68$189
Pregabalin15$168
Mupirocin18$101
Tramadol Hcl60$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →